Spirofluorene xanthene compound and organic electroluminescent element containing same

By developing spirofluoreneoxane compounds and optimizing their structure to improve the performance of organic electroluminescent materials, the shortcomings of existing organic electroluminescent elements in terms of driving voltage, luminous efficiency and lifetime have been solved, and higher performance has been achieved.

WO2026238153A1PCT designated stage Publication Date: 2026-11-19HAINING INNOVATORS TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2026/108467
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2026-05-13
Filing Date
2026-07-03
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

There is room for improvement in existing organic electroluminescent devices in terms of driving voltage, luminous efficiency, and lifetime. Therefore, it is necessary to develop high-performance organic electroluminescent materials to improve device performance.

Method used

A spirofluorenexanthracene compound is provided, which improves the performance of the material by optimizing the substituents and linking groups in its structure, thereby enhancing the performance of organic electroluminescent elements.

Benefits of technology

By using spirofluorene-xanthracene compounds, the driving voltage was reduced, the luminous efficiency and device stability were improved, and the service life was extended.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2026108467_19112026_PF_FP_ABST
    Figure CN2026108467_19112026_PF_FP_ABST
Patent Text Reader

Abstract

The present application relates to the technical field of organic electroluminescence, and more particularly relates to a spirofluorene xanthene compound, a material for an organic element, an organic electroluminescent element, and a display or lighting device. Provided is a spirofluorene xanthene compound. The structure of the spirofluorene xanthene compound is as represented by formula (1) below. The spirofluorene xanthene compound provided by the present application has a lower driving voltage and a longer service life, and is suitable for the preparation of a high-performance organic electroluminescent element.
Need to check novelty before this filing date? Find Prior Art

Description

A spirofluorene-xanthracene compound and an organic electroluminescent element comprising the same.

[0001] Cross-reference to related applications

[0002] This application claims priority and benefits to the following Chinese patent application filed with the China National Intellectual Property Administration, the entire contents of which are incorporated herein by reference:

[0003] Chinese patent application filed on May 15, 2025, with application number CN202510623929.8 and application title "A spirofluorenexanthracene compound and an organic electroluminescent element comprising the same";

[0004] Chinese patent application filed on May 13, 2026, with application number CN202610658401.9 and application title "A spirofluorenexanthracene compound and an organic electroluminescent element comprising the same". Technical Field

[0005] This application relates to the field of organic electroluminescence technology, and more specifically, to a spirofluoreneoxane compound, materials for organic components, organic electroluminescent elements, and display or lighting devices. Background Technology

[0006] Organic light-emitting elements (OLEDs) are self-emissive display devices based on organic electroluminescent materials. Compared with existing liquid crystal display devices, they have the advantages of not requiring a backlight and being thin. They are a technology suitable for flexible device devices (flexible light-emitting display devices) and can be used to manufacture new display products as well as new lighting products, with a very wide range of applications.

[0007] Organic electroluminescent devices include an anode, a cathode, and an organic functional layer located between the anode and the cathode. The organic functional layer is composed of a multilayer structure made of various materials, such as a hole injection layer, a hole transport layer, a second hole transport layer, a light-emitting layer, a hole blocking layer, an electron transport layer, an N-type charge generation layer, a P-type charge generation layer, a hole transport layer, a second hole transport layer, a light-emitting layer, a hole blocking layer, an electron transport layer, and a second electrode layer. This allows charge carriers of holes and electrons to recombine in the light-emitting layer. The recombination of charge carriers generates excitons, which then transition from the excited state to the ground state to produce light.

[0008] Current research on improving the performance of organic electroluminescent devices includes reducing the driving voltage, increasing the luminous efficiency, extending the lifespan, and enhancing stability. The characteristics of the organic compounds contained in each layer significantly influence the driving voltage and lifespan of the device; therefore, using specific organic materials with superior performance is considered important in organic electroluminescent devices.

[0009] Therefore, continuous research and innovation are needed to develop organic electroluminescent functional materials, produce higher-performance organic electroluminescent functional materials, and then manufacture organic electroluminescent devices with excellent performance. Summary of the Invention

[0010] The technical problem to be solved by this application is to further develop a spirofluorene-xanthracene compound that can be used as a novel organic electroluminescent material, thereby improving the performance of organic electroluminescent elements.

[0011] The technical solution of this application is as follows:

[0012] In a first aspect, this application provides a spirofluoreneoxanthracene compound, the structure of which is preferably shown in Formula 1 below:

[0013] In the compound with the structure of Formula 1, Ar 1 Ar 2 One of them is preferably hydrogen, and the other is preferably a group with the structure of Formula 2:

[0014] In the groups of the structure of Formula 2,

[0015] R 1 R 2 Each is independently selected from substituted or unsubstituted C1-C. 10 Alkyl, substituted or unsubstituted C6-C 60 The aryl group is preferably selected from substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted propyl, substituted or unsubstituted n-butyl, substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl, substituted or unsubstituted terphenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthracene, substituted or unsubstituted phenanthryl, substituted or unsubstituted pyrene, substituted or unsubstituted fluoranthyl, substituted or unsubstituted triphenylene, substituted or unsubstituted The fluorenyl group, substituted or unsubstituted, or spirofluorenyl group, is preferably selected from substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl, substituted or unsubstituted terphenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthracene, or substituted or unsubstituted phenanthryl, preferably selected from substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted phenyl, or substituted or unsubstituted phenanthryl. The biphenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted phenanthryl, more preferably selected from substituted or unsubstituted methyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl, substituted or unsubstituted naphthyl, particularly preferably selected from substituted or unsubstituted methyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, particularly preferably selected from substituted or unsubstituted naphthyl, substituted or unsubstituted phenyl, especially preferably selected from substituted or unsubstituted phenyl, most preferably selected from unsubstituted phenyl;

[0016] L 1 Selected from linker, substituted or unsubstituted C6-C 60 The arylene group is preferably selected from the following: a linking bond, a substituted or unsubstituted phenylene group, a substituted or unsubstituted biphenylene group, a substituted or unsubstituted terphenylene group, a substituted or unsubstituted naphthylene group, a substituted or unsubstituted anthracene group, a substituted or unsubstituted phenanthylene group, a substituted or unsubstituted pyrene group, a substituted or unsubstituted fluoranthylene group, a substituted or unsubstituted terphenylene group, a substituted or unsubstituted arylene group. The group consists of a substituted or unsubstituted fluoreneyl group, a substituted or unsubstituted spirofluoreneyl group, preferably selected from the following: a linking bond; a substituted or unsubstituted phenylene group; a substituted or unsubstituted biphenylene group; a substituted or unsubstituted terphenylene group; a substituted or unsubstituted naphthylene group; a substituted or unsubstituted anthraceneylene group; a substituted or unsubstituted phenanthreneylene group; a substituted or unsubstituted pyreneylene group; a substituted or unsubstituted fluoranthylene group; a substituted or unsubstituted tripylidene group; a substituted or unsubstituted phenanthreneylene ... The group is more preferably selected from the linking bond, substituted or unsubstituted phenylene, substituted or unsubstituted biphenylene, substituted or unsubstituted terphenylene, substituted or unsubstituted naphthylene, substituted or unsubstituted anthracene, substituted or unsubstituted phenanthrene, particularly preferably selected from the linking bond, substituted or unsubstituted phenylene, substituted or unsubstituted biphenylene, substituted or unsubstituted naphthylene, substituted or unsubstituted phenanthrene, especially preferably selected from the linking bond, substituted or unsubstituted phenylene, substituted or unsubstituted biphenylene, substituted or unsubstituted naphthylene, particularly preferably selected from the linking bond, substituted or unsubstituted phenylene, substituted or unsubstituted naphthylene, particularly preferably selected from the linking bond, substituted or unsubstituted phenylene, most preferably selected from the linking bond;

[0017] In the compound with the structure of Formula 1, Ar 3 Ar 4 One of them is preferably hydrogen, and the other is preferably a group with the structure of Formula 3:

[0018] In the groups of the structure of Formula 3,

[0019] R 3 Selected from hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C1-C 10 Alkyl, substituted or unsubstituted C6-C 60 aryl, substituted or unsubstituted C2-C 60 The heteroaryl group is preferably hydrogen, deuterium, fluorine, cyano, substituted or unsubstituted C1-C. 10 Alkyl, substituted or unsubstituted C6-C 60 aryl, substituted or unsubstituted C2-C 60 The heteroaryl group, more preferably hydrogen, deuterium, fluoro, cyano, substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted propyl, substituted or unsubstituted n-butyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl, substituted or unsubstituted terphenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthracene, substituted or unsubstituted phenanthyl, substituted or unsubstituted pyrene, substituted or unsubstituted fluoranthyl, substituted or unsubstituted quinolinyl, substituted or unsubstituted fluorenyl, substituted or unsubstituted spirofluorenyl, substituted or unsubstituted triphenylene, substituted or unsubstituted Substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted dibenzothiopheneyl, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrroleyl, substituted or unsubstituted phenylpropofuryl, substituted or unsubstituted benzothiopheneyl, substituted or unsubstituted oxazole, substituted or unsubstituted benzoxazole, substituted or unsubstituted furanyl, substituted or unsubstituted thiopheneyl, substituted or unsubstituted carbazoleyl, substituted or unsubstituted isoquinolinyl, substituted or unsubstituted indolyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted triazineyl, substituted or unsubstituted bipyridyl, substituted or unsubstituted terpyridyl, particularly preferably hydrogen Deuterium, fluorine, cyano, substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted quinolinyl, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrroleyl, substituted or unsubstituted phenylpropionyl, substituted or unsubstituted benzothiophene, substituted or unsubstituted oxazole, substituted or unsubstituted benzoxazole, substituted or unsubstituted furanyl, substituted or unsubstituted thiophene, substituted or unsubstituted isoquinolinyl, substituted or unsubstituted indole, substituted or unsubstituted pyrimidinyl, substituted or Unsubstituted triazine group, particularly preferably hydrogen, deuterium, fluoro, cyano, substituted or unsubstituted methyl, substituted or unsubstituted ethyl, substituted or unsubstituted tert-butyl, substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrrole, substituted or unsubstituted oxazole, substituted or unsubstituted benzoxazole, especially preferably hydrogen, deuterium, fluoro, cyano, substituted or unsubstituted tert-butyl, substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted pyridyl, especially preferably hydrogen, deuterium, fluoro The radical, cyano, substituted or unsubstituted tert-butyl, substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl, substituted or unsubstituted pyridyl, particularly preferably hydrogen, deuterium, fluoro, substituted or unsubstituted tert-butyl, substituted or unsubstituted phenyl, substituted or unsubstituted pyridyl, particularly preferably hydrogen, deuterium, fluoro, substituted or unsubstituted phenyl, substituted or unsubstituted pyridyl, particularly preferably hydrogen, deuterium, substituted or unsubstituted phenyl, most preferably substituted or unsubstituted phenyl;

[0020] n is an integer from 0 to 7, more preferably an integer from 0 to 6, more preferably an integer from 0 to 5, more preferably an integer from 0 to 4, more preferably 0, 1, 2, 3, more preferably 0, 1, 2, particularly preferably 0, 1, and most preferably 0; when n is 2 or greater, multiple R 3 They are the same or different from each other;

[0021] Indicates a connection key;

[0022] The substituents in the "substituted or unsubstituted" category are each independently selected from deuterium, halogen, cyano, C1-C. 10 Alkyl, C1-C 10 alkoxy groups, C3-C 10 cycloalkyl, C3-C 10 Cycloalkoxy, C6-C 60 aryl, C6-C 60 aryloxy groups, C2-C 60 One or a combination of heteroaryl groups; preferably selected from deuterium, halogen, cyano, C1-C 10 Alkyl, C1-C 10 alkoxy groups, C3-C 10 cycloalkyl, C3-C 10 Cycloalkoxy, C6-C 60 aryl, C2-C 60 One or a combination of heteroaryl groups; more preferably selected from deuterium, halogen, cyano, C1-C 10 Alkyl, C1-C 10 alkoxy groups, C3-C 10 cycloalkyl, C6-C 60 aryl, C2-C 60 One or a combination of heteroaryl groups; more preferably selected from deuterium, halogen, cyano, C1-C 10 Alkyl, C3-C 10 cycloalkyl, C6-C 60 aryl, C2-C 60 One or a combination of heteroaryl groups; more preferably selected from deuterium, fluoro, cyano, C1-C 10 Alkyl, C3-C 10 cycloalkyl, C6-C 60 aryl, C2-C 60 One or a combination of heteroaryl groups; more preferably selected from deuterium, fluoro, cyano, C1-C 10 Alkyl, C6-C 60 aryl, C2-C 60 One or a combination of heteroaryl groups; more preferably selected from deuterium, fluoro, cyano, C1-C 10 Alkyl, C6-C 60 One or a combination of aryl groups; particularly preferably selected from deuterium, fluorine, cyano, C6-C 60One or a combination of aryl groups; particularly preferably selected from one or a combination of deuterium, fluoro group, and cyano group; particularly preferably selected from one or a combination of deuterium and fluoro group; most preferably selected from one or a combination of deuterium.

[0023] The heteroatoms in the heteroaryl group are preferably selected from one or more of N, O, S, Si, P, and B, more preferably selected from one or more of N, O, S, Si, and P, more preferably selected from one or more of N, O, S, and P, more preferably selected from one or more of N, O, and S, particularly preferably selected from one or more of N and O, and most preferably selected from one or more of N and O.

[0024] Preferably, the compound may not contain or may contain at least one substituent selected from deuterium, fluorine, or cyano; more preferably, the compound may not contain or may contain at least one substituent selected from deuterium or fluorine; more preferably, the compound may not contain or may contain at least one deuterium.

[0025] According to the above-mentioned spirofluorene xanthracene compounds, the groups of the structure of Formula 2 are preferably selected from the following structures:

[0026] Among them, R 1 R 2 Each is independently selected from substituted or unsubstituted methyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, preferably from unsubstituted methyl, unsubstituted phenyl, unsubstituted naphthyl, more preferably from... More preferably selected More preferably selected The best selection is selected from

[0027] The groups in the structure of Formula 2 are preferably selected from the following structures:

[0028] The groups of the structure of Formula 2 are more preferably selected from the following structures:

[0029] The groups of the structure of Formula 2 are more preferably selected from the following structures:

[0030] The groups in the structure of Formula 2 are most preferably selected from the following structures:

[0031] Among them, L 1 The definition is the same as above;

[0032] Indicates a connection key;

[0033] The definition of substituents in the phrase "substituted or unsubstituted" is the same as above;

[0034] Preferably, the above-mentioned group is unsubstituted or substituted with one or more substituents selected from deuterium, fluorine, and cyano; more preferably, the above-mentioned group is unsubstituted or substituted with one or more substituents selected from deuterium and fluorine; more preferably, the above-mentioned group is unsubstituted or substituted with one or more deuterium groups; even more preferably, the above-mentioned group is unsubstituted or substituted with one or more deuterium groups; most preferably, the above-mentioned group is unsubstituted.

[0035] Based on the above-mentioned spirofluorene-xanthracene compounds, the preferred structures of the spirofluorene-xanthracene compounds are shown in Formulas 4, 5, 6, and 7 below:

[0036] Among them, Ar 3 Ar 4 Groups with the following structure (Formula 3):

[0037] L 1 R 3 The definitions of n are the same as above;

[0038] Indicates a connection key;

[0039] Preferably, the compound may not contain or may contain at least one substituent selected from deuterium, fluorine, or cyano; more preferably, the compound may not contain or may contain at least one substituent selected from deuterium or fluorine; more preferably, the compound may not contain or may contain at least one deuterium.

[0040] According to the above-mentioned spirofluorene xanthracene compounds, the groups of the structure of Formula 3 are preferably selected from the following structures:

[0041] R 3 The definitions of n are the same as above;

[0042] The groups in the structure of Formula 3 are preferably selected from the following structures:

[0043] R 3 Preferably, it is hydrogen, deuterium, substituted or unsubstituted phenyl, or substituted or unsubstituted pyridyl; more preferably, it is hydrogen, deuterium, or substituted or unsubstituted. Replaced or not replaced Replaced or not replaced Replaced or not replaced Preferred to be hydrogen, deuterium, unsubstituted or substituted with deuterium, fluorine, cyano, tert-butyl, pyridyl, or phenyl. Unsubstituted or substituted with deuterium, fluorine, cyano, tert-butyl, pyridyl, or phenyl Unsubstituted or substituted with deuterium, fluorine, cyano, tert-butyl, pyridyl, or phenyl Unsubstituted or substituted with deuterium, fluorine, cyano, tert-butyl, pyridyl, or phenyl Preferred to be hydrogen, deuterium, unsubstituted or substituted with deuterium, fluorine, or tert-butyl. Unsubstituted or substituted with deuterium, fluorine, or tert-butyl groups Unsubstituted or substituted with deuterium, fluorine, or tert-butyl groups Unsubstituted or substituted with deuterium, fluorine, or tert-butyl groups Preferred to be hydrogen, deuterium, unsubstituted or substituted with deuterium, fluorine, or tert-butyl. Unsubstituted or substituted with deuterium, fluorine, or tert-butyl groups Unsubstituted or substituted with deuterium, fluorine, or tert-butyl groups More preferably, it is hydrogen, deuterium, unsubstituted or substituted with deuterium, fluorine, or tert-butyl. Unsubstituted or substituted with deuterium, fluorine, or tert-butyl groups More preferably, it is hydrogen, deuterium, unsubstituted or substituted with deuterium, fluorine, or tert-butyl. Particularly preferred are hydrogen, unsubstituted, or substituted with deuterium, fluorine, or tert-butyl groups. Particularly preferred are unsubstituted or substituted with deuterium, fluorine, or tert-butyl groups. Particularly preferred are unsubstituted or fluorinated or tert-butyl substituted compounds. Particularly preferred are unsubstituted or fluorinated compounds. The most preferred is unsubstituted.

[0044] The definition of n is the same as above;

[0045] The groups in the structure of Formula 3 are more preferably selected from the following structures:

[0046] R 3 The definition is the same as above;

[0047] The groups in the structure of Formula 3 are particularly preferably selected from the following structures:

[0048] R 3 The definition is the same as above;

[0049] The groups in the structure of Formula 3 are particularly preferably selected from the following structures:

[0050] R 3 The definition is the same as above;

[0051] The groups in the structure of Formula 3 are particularly preferably selected from the following structures:

[0052] R 3 The definition is the same as above;

[0053] in, Indicates a connection key;

[0054] The definition of substituents in the phrase "substituted or unsubstituted" is the same as above;

[0055] Preferably, the above-mentioned group is unsubstituted or substituted with one or more substituents selected from deuterium, fluorine, and cyano; more preferably, the above-mentioned group is unsubstituted or substituted with one or more substituents selected from deuterium and fluorine; more preferably, the above-mentioned group is unsubstituted or substituted with one or more deuterium groups; even more preferably, the above-mentioned group is unsubstituted or substituted with one or more deuterium groups; most preferably, the above-mentioned group is unsubstituted.

[0056] Based on the above-mentioned spirofluorene-xanthracene compounds, the preferred structures of the spirofluorene-xanthracene compounds are as shown in Formulas 4-1, 4-2, 5-1, 5-2, 6-1, 6-2, 7-1, and 7-2:

[0057] Among them, L 1 R 3 The definition is the same as above;

[0058] Preferably, the compound may not contain or may contain at least one substituent selected from deuterium, fluorine, or cyano; more preferably, the compound may not contain or may contain at least one substituent selected from deuterium or fluorine; more preferably, the compound may not contain or may contain at least one deuterium.

[0059] According to the above-mentioned spirofluoroxanthracene compounds, the spirofluoroxanthyl group in the structure of the spirofluoroxanthracene compound is preferably selected from the following structures:

[0060] in, Indicates a replacement position;

[0061] Two of the above-mentioned spirofluorenexanthracene groups A with L 1 One is directly connected, and the other is directly connected to a phenanthroline group;

[0062] Preferably, the above-mentioned group is unsubstituted or substituted with one or more substituents selected from deuterium, fluorine, and cyano; more preferably, the above-mentioned group is unsubstituted or substituted with one or more substituents selected from deuterium and fluorine; more preferably, the above-mentioned group is unsubstituted or substituted with one or more deuterium groups; even more preferably, the above-mentioned group is unsubstituted or substituted with one or more deuterium groups; most preferably, the above-mentioned group is unsubstituted.

[0063] Based on the above-mentioned spirofluorenexanthracene compounds, the structure of the spirofluorenexanthracene compounds is preferably as follows:

[0064] Among them, L 1 R 3 The definition is the same as above;

[0065] Preferably, the compound may not contain or may contain at least one substituent selected from deuterium, fluorine, or cyano; more preferably, the compound may not contain or may contain at least one substituent selected from deuterium or fluorine; more preferably, the compound may not contain or may contain at least one deuterium.

[0066] Based on the above-mentioned spirofluorenexanthracene compounds, the structure of the spirofluorenexanthracene compounds is preferably as follows:

[0067] The preferred embodiment is shown below:

[0068] More preferably as follows

[0069] Particularly preferred are those shown below.

[0070] Particularly preferred are those shown below.

[0071] Particularly preferred are those shown below.

[0072] The most preferred option is as follows:

[0073] Among them, L 1 R 3 The definition is the same as above;

[0074] Preferably, the compound may not contain or may contain at least one substituent selected from deuterium, fluorine, or cyano; more preferably, the compound may not contain or may contain at least one substituent selected from deuterium or fluorine; more preferably, the compound may not contain or may contain at least one deuterium.

[0075] According to the above-mentioned spirofluorene xanthracene compounds, the L 1 Preferably selected from linking groups, substituted or unsubstituted phenylene, substituted or unsubstituted naphthylene, more preferably selected from linking groups, unsubstituted phenylene, unsubstituted naphthylene, more preferably selected from linking groups, or the following groups:

[0076] More preferably selected from linking bonds, or the following groups: Particularly preferred are those selected from linking bonds, or the following groups: Particularly preferred are those selected from linking bonds, or the following groups: Particularly preferred are those selected from linking bonds, or the following groups: The most preferred option is a connecting key;

[0077] in, Indicates a connection key;

[0078] The definition of substituents in the phrase "substituted or unsubstituted" is the same as above;

[0079] Preferably, the above-mentioned group is unsubstituted or substituted with one or more substituents selected from deuterium, fluorine, and cyano; more preferably, the above-mentioned group is unsubstituted or substituted with one or more substituents selected from deuterium and fluorine; more preferably, the above-mentioned group is unsubstituted or substituted with one or more deuterium groups; even more preferably, the above-mentioned group is unsubstituted or substituted with one or more deuterium groups; most preferably, the above-mentioned group is unsubstituted.

[0080] According to the above-mentioned spirofluorene-xanthracene compounds, the halogen is preferably F, Br, Cl, or I;

[0081] And / or, the C1-C 10 The alkyl group is preferably methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, neopentyl, isopentyl, n-hexyl, n-heptyl, n-octyl, n-decyl, isooctyl, nonyl, 2-ethylhexyl;

[0082] And / or, the C6-C 60 The aryl group is preferably phenyl, biphenyl, terphenyl, naphthyl, anthracene, tetraphenyl, phenanthrene, fluorenyl, indene, pyrene, perylene, fluoranyl, benzophenanthrene, triphenylene, etc. Benzyl, spirofluorenyl, benzo[a]pyrene, benzo[a] base;

[0083] And / or, the C6-C 60 The arylene group is preferably phenylene, biphenylene, terphenylene, naphthylene, anthracene, tetraphenylene, phenanthrene, fluorene, indene, pyrene, perylene, fluoranthracene, benzophenanthrene, triphenylene, etc. alkyl, spirofluorene, benzo[a]pyrene, benzo[a]pyrene base;

[0084] And / or, the C2-C 60The heteroaryl groups are preferably thienyl, furanyl, pyrroleyl, thiazolyl, oxazolyl, imidazolyl, pyrazolyl, triazolyl, benzothienyl, benzofuranyl, indolyl, isoindolyl, benzothiazolyl, benzooxazolyl, benzoimidazolyl, benzotriazolyl, purinyl, carbazoleyl, dibenzothienyl, dibenzofuranyl, pyridyl, pyrimidinyl, triazinyl, phenazinyl, quinolinyl, isoquinolinyl, naphridinyl, acridineyl, phenanthrolinel, carbolinyl, bipyridinyl, and terpyridinyl.

[0085] And / or, the C1-C 10 The preferred alkoxy groups are methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentoxy, neopentoxy, isopentoxy, n-hexyloxy, n-octoxy, isooctoxy, n-decoxy, n-nonoxy, and n-heptoxy.

[0086] And / or, the C3-C 10 The cycloalkyl group is preferably cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclooctyl, cyclononyl, cyclodecyl, norbornyl, or adamantane;

[0087] And / or, the C3-C 10 The cycloalkoxy group is preferably cyclopropoxy, cyclobutoxy, cyclopentoxy, cyclohexoxy, cycloheptoxy, cyclooctoxy, cyclononoxy, or cyclodecoxy.

[0088] And / or, the C6-C 30 The aryloxy group is preferably phenoxy, toluoxy, biphenyloxy, naphthoxy, anthraquinoneoxy, phenanthreneoxy, or benzyloxy.

[0089] According to the above-mentioned spirofluorene-xanthracene compounds, the halogen is preferably F, Br, Cl, or I, more preferably F, Br, or Cl, more preferably F or Cl, and most preferably F.

[0090] According to the above-mentioned spirofluorene xanthracene compounds, the C1-C 10The alkyl group is preferably methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, neopentyl, isopentyl, n-hexyl, n-heptyl, n-octyl, n-decyl, isooctyl, nonyl, 2-ethylhexyl, more preferably methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, neopentyl, isopentyl, n-hexyl, n-octyl, n-heptane, and even more preferably methyl, ethyl, n-propyl, isopropyl, n-... Butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, neopentyl, isopentyl, n-hexyl, more preferably methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, particularly preferably methyl, ethyl, n-propyl, isopropyl, tert-butyl, n-pentyl, especially preferably methyl, ethyl, n-propyl, isopropyl, tert-butyl, particularly preferably methyl, ethyl, tert-butyl, particularly preferably methyl, ethyl, most preferably methyl.

[0091] According to the above-mentioned spirofluorene xanthracene compounds, the C6-C 60 The aryl group is preferably phenyl, biphenyl, terphenyl, naphthyl, anthracene, tetraphenyl, phenanthrene, fluorenyl, indene, pyrene, perylene, fluoranyl, benzophenanthrene, triphenylene, etc. Benzyl, spirofluorenyl, benzo[a]pyrene, benzo[a] The preferred radicals are phenyl, biphenyl, terphenyl, naphthyl, anthracene, phenanthrene, fluoranthyl, triphenylene, perylene, pyrene, benzo[a]pyrene, etc. Benzyl, benzo[ The radical is more preferably phenyl, biphenyl, terphenyl, naphthyl, anthraceneyl, or phenanthryl, especially preferably biphenyl, phenyl, or naphthyl, particularly preferably phenyl or naphthyl, and most preferably phenyl.

[0092] According to the above-mentioned spirofluorene xanthracene compounds, the C6-C 60 The arylene group is preferably phenylene, biphenylene, terphenylene, naphthylene, anthracene, tetraphenylene, phenanthrene, fluorene, indene, pyrene, perylene, fluoranthracene, benzophenanthrene, triphenylene, etc. alkyl, spirofluorene, benzo[a]pyrene, benzo[a]pyrene The preferred radicals are phenylene, biphenylene, terphenylene, naphthylene, anthraceneylene, phenanthrene, fluorenethracene, terphenylene, perylene, pyrene, benzo[a]pyrene, and so on. Benzyl, benzo[a] The radical is more preferably phenylene, biphenylene, terphenylene, naphthylene, anthraceneylene, or phenanthrene, especially preferably biphenylene, phenylene, or naphthylene, and most preferably phenylene or naphthylene.

[0093] According to the above-mentioned spirofluorene xanthracene compounds, the C2-C 60 The heteroaryl group is preferably thienyl, furanyl, pyrrolyl, thiazolyl, oxazolyl, imidazolyl, pyrazolyl, triazolyl, benzothienyl, bipyridyl, terpyridyl, benzofuranyl, indolyl, isoindolyl, benzothiazolyl, benzooxazolyl, benzoimidazolyl, benzotriazolyl, purinyl, carbazoleyl, dibenzothienyl, dibenzofuranyl, pyridyl, pyrimidinyl, triazinyl, phenazinyl, quinolinyl, isoquinolinyl, naphridyl, acridineyl, phenanthrolinel, carbolinyl, and more preferably thienyl, furanyl, bipyridyl, terpyridyl, or pyrrolyl. Imidazolyl, pyrazolyl, benzothiophene, benzofuranyl, benzoimidazolyl, carbazole, dibenzothiophene, dibenzofuranyl, pyridyl, pyrimidinyl, triazine, phenazine, quinolinyl, isoquinolinyl, phenanthroline, more preferably pyrroleyl, imidazolyl, carbazole, dibenzothiophene, bipyridyl, terpyridyl, dibenzofuranyl, pyridyl, pyrimidinyl, triazine, particularly preferably dibenzothiophene, dibenzofuranyl, pyridyl, triazine, especially preferably dibenzothiophene, dibenzofuranyl, pyridyl, most preferably pyridyl.

[0094] According to the above-mentioned spirofluorene xanthracene compounds, the C1-C 10 The alkoxy group is preferably methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentoxy, neopentoxy, isopentoxy, n-hexyloxy, n-octoxy, isooctoxy, n-decoxy, n-nonoxy, n-heptoxy, more preferably methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentoxy, neopentoxy, isopentoxy, n-hexyloxy, n-octyloxy, n-heptoxy, and even more preferably methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, n-butoxy Oxygen, isobutoxy, tert-butoxy, sec-butoxy, n-pentoxy, neopentoxy, isopentoxy, n-hexyloxy, more preferably methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentoxy, particularly preferably methoxy, ethoxy, n-propoxy, isopropoxy, tert-butoxy, n-pentoxy, especially preferably methoxy, ethoxy, n-propoxy, isopropoxy, tert-butoxy, particularly preferably methoxy, ethoxy, tert-butoxy, particularly preferably methoxy, ethoxy, most preferably methoxy.

[0095] According to the above-mentioned spirofluorene xanthracene compounds, the C3-C 10The cycloalkyl group is preferably cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclooctyl, cyclononyl, cyclodecyl, norbornyl, or adamantane; more preferably cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, or adamantane; more preferably cyclopropyl, cyclopentyl, cyclohexyl, or adamantane; particularly preferably cyclopropyl, cyclopentyl, or cyclohexyl; especially preferably cyclohexyl or cyclopropyl; and most preferably cyclohexyl.

[0096] According to the above-mentioned spirofluorene xanthracene compounds, the C3-C 10 The cycloalkoxy group is preferably cyclopropoxy, cyclobutoxy, cyclopentoxy, cyclohexyloxy, cycloheptoxy, cyclooctoxy, cyclononoxy, or cyclodecoxy, more preferably cyclopropoxy, cyclobutoxy, cyclopentoxy, cyclohexyloxy, or cycloheptoxy, more preferably cyclopropoxy, cyclobutoxy, cyclopentoxy, or cyclohexyloxy, particularly preferably cyclopropoxy, cyclobutoxy, or cyclopentoxy, especially preferably cyclopropoxy or cyclopentoxy, and most preferably cyclopropoxy.

[0097] According to the above-mentioned spirofluorene xanthracene compounds, the C6-C 30 The aryloxy group is preferably phenoxy, toluoxy, biphenyloxy, naphthoxy, anthraquinoneoxy, phenanthreneoxy, or benzyloxy, more preferably phenoxy, toluoxy, or benzyloxy, more preferably phenoxy or toluoxy, and most preferably phenoxy.

[0098] According to the above-mentioned spirofluoreneoxanthracene compounds, the substituents in the phrase "substituted or unsubstituted" are preferably each independently selected from deuterium, fluorinyl, cyano, methyl, ethyl, propyl, n-butyl, tert-butyl, cyclopentyl, cyclohexyl, adamantyl, fluorenyl, spirofluorenyl, phenyl, biphenyl, terphenyl, naphthyl, anthraceneyl, phenanthryl, pyrene, fluoranyl, triphenylene, etc. The following are combinations of one or more of the following: alkyl, dibenzofuranyl, carbazoleyl, phenanolyl, dibenzothiophenyl, pyrrolyl, furanyl, triazinyl, pyrazinyl, pyridazinyl, oxazolyl, thiophenyl, benzothiophenyl, benzofuranyl, benzooxazolyl, imidazolyl, quinazolinyl, methoxy, ethoxy, propoxy, n-butoxy, tert-butoxy, indoleyl, indazoleyl, thiophenyl, pyridyl, pyrimidinyl, quinolinyl, isoquinolinyl, and pyridinyl; preferably selected from deuterium, fluorinyl, cyano, methyl, ethyl, propyl, tert-butyl, cyclopentyl, cyclohexyl, adamantyl, fluorenyl, phenyl, biphenyl, naphthyl, anthraceneyl, dibenzofuranyl, carbazoleyl, phenanolyl, dibenzothiophenyl, pyrrolyl, and furanyl. The radical is selected from one or more combinations of the following: alkyl, triazinyl, oxazolyl, thiophenyl, benzothiophenyl, benzofuranyl, benzooxazolyl, imidazolyl, thiophenyl, pyridyl, pyrimidinyl, quinolinyl, isoquinolinyl, and pyridinyl; more preferably selected from one or more combinations of deuterium, fluoro, cyano, methyl, tert-butyl, cyclopentyl, cyclohexyl, adamantyl, phenyl, biphenyl, naphthyl, anthraceneyl, dibenzofuranyl, dibenzothiophenyl, pyrroleyl, furanyl, thiophenyl, benzothiophenyl, benzofuranyl, pyridinyl, pyrimidinyl, quinolinyl, and isoquinolinyl; particularly preferably selected from one or more combinations of the following: deuterium, fluoro, cyano, methyl, cyclopentyl, cyclohexyl, phenyl, biphenyl, naphthyl, anthraceneyl, dibenzofuranyl, diphenyl... The compound is selected from one or more combinations of thiophene, pyridyl, pyrimidinyl, quinolinyl, and isoquinolinyl; particularly preferably selected from one or more combinations of deuterium, fluorine, cyano, methyl, phenyl, biphenyl, naphthyl, anthracene, dibenzofuranyl, dibenzothiophene, pyridyl, pyrimidinyl, quinolinyl, and isoquinolinyl; especially preferably selected from one or more combinations of deuterium, fluorine, cyano, methyl, phenyl, dibenzofuranyl, pyridyl, pyrimidinyl, quinolinyl, and isoquinolinyl; particularly preferably selected from one or more combinations of deuterium, fluorine, cyano, methyl, phenyl, dibenzofuranyl, pyridyl, pyrimidinyl, quinolinyl, and isoquinolinyl; particularly preferably selected from one or more combinations of deuterium, fluorine, cyano, methyl, phenyl, dibenzofuranyl, pyridyl, pyrimidinyl, quinolinyl, and isoquinolinyl; particularly preferably selected from deuterium, fluorine, cyano, methyl The compound is selected from one or more combinations of deuterium, fluoro, cyano, methyl, phenyl, dibenzofuranyl, and pyridinyl; particularly preferably selected from one or more combinations of deuterium, fluoro, cyano, methyl, phenyl, and pyridinyl; particularly preferably selected from one or more combinations of deuterium, fluoro, cyano, methyl, and phenyl; particularly preferably selected from one or more combinations of deuterium, fluoro, methyl, and phenyl; particularly preferably selected from one or more combinations of deuterium, fluoro, and phenyl; particularly preferably selected from one or more combinations of deuterium and phenyl; most preferably selected from one or more combinations of deuterium.

[0099] According to the above-mentioned spirofluorenexanthracene compounds, the spirofluorenexanthracene compounds are preferably selected from the structures shown below:

[0100] Secondly, this application provides a material for organic components, which may contain the above-mentioned spirofluoreneoxane compounds; preferably, the material is an electron transport layer material, a hole blocking layer material, an electron injection layer material, or a charge generation layer material; more preferably, the material is an electron transport layer material or a charge generation layer material; more preferably, the material is a charge generation layer material; most preferably, the material is an N-type charge generation layer material.

[0101] Thirdly, this application provides an organic electroluminescent element, which may contain the above-mentioned spirofluoreneoxane compound or the above-mentioned organic element material.

[0102] According to the above-mentioned organic electroluminescent element, the organic electroluminescent element preferably includes a cathode, an anode, and an organic functional layer located between the anode and the cathode, wherein at least one layer of the organic functional layer contains the above-mentioned spirofluorene-oxanthracene compound or the above-mentioned organic element material; preferably, the organic layer contains at least two light-emitting units, and a charge-generating layer is included between the light-emitting units, wherein the charge-generating layer includes an N-type charge-generating layer and a P-type charge-generating layer, and the N-type charge-generating layer contains the spirofluorene-oxanthracene compound described in this application.

[0103] Preferably, the N-type charge generation layer further includes a metal, which is selected from any one of alkali metals, alkaline earth metals, and rare earth metals.

[0104] Preferably, an N-type charge generating layer contains one spirofluorenexanthracene compound as described in this application; or an N-type charge generating layer contains multiple spirofluorenexanthracene compounds as described in this application; or multiple N-type charge generating layers contain one spirofluorenexanthracene compound as described in this application; or multiple N-type charge generating layers contain multiple spirofluorenexanthracene compounds as described in this application, etc.

[0105] When an organic electroluminescent element contains two or more spirofluoreneoxane compounds of this application, the organic compounds may be the same or different.

[0106] The stacked structure described in this application refers to n light-emitting units, where n is greater than or equal to 2, and the number of N-type charge generation layers is n-1.

[0107] Fourthly, this application provides a display or lighting device, which may include the above-mentioned spirofluorenexanthracene compound, the above-mentioned organic element material, or the above-mentioned organic electroluminescent element; preferably, the device further includes a control unit for driving the above-mentioned display device.

[0108] In this application, the term "C1-C" is used. 10 "Alkyl" refers to a monovalent substituent derived from a straight-chain or branched saturated hydrocarbon having 1 to 10 carbon atoms, examples of which include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, and hexyl.

[0109] In this application, the term "C6-C" 60 "Aryl" refers to a monovalent substituent derived from an aromatic hydrocarbon having a single ring or a combination of two or more rings and having 6 to 60 carbon atoms. Further, such an aryl group can have two or more rings simply side-attached to or fused together with each other. Examples of such aryl groups include, but are not limited to, phenyl, biphenyl, naphthyl, phenanthryl, anthracene, pyrene, triphenylene, fluoranthyl, 9,9-dimethylfluorene, 9,9-diphenylfluorene, spirodifluorene, etc.

[0110] In this application, the term "C2-C" 60 "Heteroaryl" refers to a monovalent substituent derived from a mono- or poly-heterocyclic aromatic hydrocarbon having 2 to 60 carbon atoms. In this connection, at least one carbon atom, preferably 1 to 3 carbon atoms, in the ring is substituted with a heteroatom, such as N, O, S, P, B, or Si. Furthermore, such heteroaryl can have two or more rings simply side-attached to each other, fused together, or fused with an aryl group. Examples of such heteroaryl include pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, indoleazinyl, indoleyl, indole-pyridinyl, purineyl, phenanthrolinel, quinolinyl, isoquinolinyl, quinazolinyl, quinoxalinyl, thiazolyl, imidazolyl, oxazolyl, furanyl, thiopheneyl, benzofuranyl, benzothiopheneyl, benzothiazolyl, benzoimidazolyl, benzooxazolyl, carbazoleyl, dibenzofuranyl, dibenzothiopheneyl, etc., and this application is not limited thereto.

[0111] In this application, the term "arylene" refers to a divalent aryl group derived by removing one hydrogen atom from an "aryl" group, such as a phenyl group by removing one hydrogen atom to form a phenylene group, or a naphthyl group by removing one hydrogen atom to form a naphthylene group.

[0112] In this application, the term "C1-C" is used. 10"Alkoxy" refers to a monovalent substituent represented by RO-, having 1 to 10 carbon atoms, where R refers to an alkyl group having 1 to 10 carbon atoms. Specific examples include, but are not limited to, methoxy, ethoxy, n-propoxy, isopropoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentoxy, neopentoxy, isopentoxy, and n-hexyloxy.

[0113] In this application, the term "C3-C" 10 "Cycloalkoxy" refers to a monovalent substituent represented by RO-, having 3 to 10 carbon atoms, where R refers to a cycloalkyl group with 3 to 10 carbon atoms. Specific examples include, but are not limited to, cyclopropoxy, cyclobutoxy, cyclopentoxy, and cyclohexoxy.

[0114] In this application, the term "C6-C" 30 "Aryloxy" refers to a monovalent substituent represented by RO- with 6 to 30 carbon atoms, where R refers to an aryl group with 6 to 60 carbon atoms. Examples of aryl groups include, but are not limited to, phenoxy, naphthoxy, biphenyloxy, benzyloxy, etc.

[0115] In this application, the term "C3-C" 10 "Cycloalkyl" refers to a monovalent substituent derived from a monocyclic or polycyclic nonaromatic hydrocarbon having 3 to 10 carbon atoms. Examples of such cycloalkyl groups include, but are not limited to, cyclopropane, cyclobutane, cyclopentane, cyclohexane, norbornyl, and adamantane.

[0116] In this application, the term "halogen" may include fluorine, chlorine, bromine, or iodine.

[0117] In this application, Indicates a connection key.

[0118] In this application, the term "spirofluoreneoxanthracene" refers to a structure with The chemical group whose substitution can occur at any position and can be substituted at one or more positions;

[0119] In this application, the term "phenanthroline" refers to a structure with the following structure: The chemical group whose substitution can occur at any position and can be substituted at one or more positions;

[0120] In this application, the terms "N-type charge generation layer", "N-type charge generation layer" and "N-CGL layer" have the same meaning.

[0121] In this application, the term "substituted or unsubstituted" means that the hydrogen atoms in a compound are substituted by non-hydrogen groups or are not substituted by non-hydrogen groups. The number of substituents is not limited, as long as it can be obtained through a chemical reaction. It is not limited to a specific position, as long as the hydrogen at that position can be substituted by a substituent. For example, a carbazolyl group, unless otherwise specified in this specification, contains any of the following groups, but is not limited to them.

[0122] This indicates the substitution position. "Unsubstituted" means that hydrogen atoms are retained, in which case hydrogen atoms include protium, deuterium, and tritium.

[0123] In this application, when two or more substituents are present, the two or more substituents may be the same or different.

[0124] In this application, the terms 1, 2, 1a, 1b, 1c, 1d, a, b, c, d, etc. are used. These terms are only used to distinguish the constituent elements and do not limit the nature or order of the constituent elements corresponding to the terms.

[0125] The beneficial technical effects of this application are as follows:

[0126] (1) The substituents in this application adopt a mixed structure of phosphoxy-spirofluorene-anthracite-phenanthroline, which has better heat resistance and is beneficial to improving device stability.

[0127] (2) Furthermore, since the compound of this application is used as an N-type material of the CGL layer, it can form a stable N-metal coordination bond with metals such as Li or Yb, forming a stable and flat organic-metal doped film, which suppresses the oxidation of the metal; at the same time, it reduces the energy level difference between the N-type charge generation layer and the P-type charge generation layer, thereby promoting electron injection into the N-type charge generation layer, and maximizing the electron transfer from the N-type charge generation layer to the adjacent electron transport layer, which is beneficial to improving the charge generation efficiency and device lifetime.

[0128] (3) When the compound described in this application is used as an organic electroluminescent functional layer material in OLED devices, it can effectively reduce the device driving voltage and improve the device life. It has good application effect in OLED light-emitting devices and has good industrialization prospects. Attached Figure Description

[0129] Figure 1 is a schematic diagram of the structure of the organic electroluminescent element described in Application Example 1; wherein: the labels in Figure 1 represent: 1, first electrode layer, 2, hole injection layer, 3, hole transport layer, 4, second hole transport layer, 5, light-emitting layer, 6, hole blocking layer, 7, electron transport layer, 8, N-type charge generation layer, 9, P-type charge generation layer, 10, hole transport layer, 11, second hole transport layer, 12, light-emitting layer, 13, hole blocking layer, 14, electron transport layer, 15, electron injection layer, 16, second electrode layer, 100, first light-emitting unit, 200, second light-emitting unit.

[0130] Figure 2 is the mass spectrum (LC-MS) of compound 1-1 prepared in synthesis example 1 in the compound preparation examples.

[0131] Figure 3 is the nuclear magnetic resonance (¹H NMR) spectrum of compound 1-1 prepared in synthesis example 1 of the compound preparation examples.

[0132] Figure 4 is the mass spectrum (LC-MS) of compounds 1-2 prepared in Synthesis Example 2 in the compound preparation examples.

[0133] Figure 5 shows the nuclear magnetic resonance (¹H NMR) spectra of compounds 1-2 prepared in synthesis example 2 of the compound preparation examples.

[0134] Figure 6 is the mass spectrum (LC-MS) of compounds 1-3 prepared in synthesis example 3 in the compound preparation examples.

[0135] Figure 7 shows the nuclear magnetic resonance (¹H NMR) spectra of compounds 1-3 prepared in synthesis example 3 in the compound preparation examples.

[0136] Figure 8 shows the mass spectra (LC-MS) of compounds 1-7 prepared in Synthesis Example 4 in the compound preparation examples.

[0137] Figure 9 shows the nuclear magnetic resonance (¹H NMR) spectra of compounds 1-7 prepared in synthesis example 4 in the compound preparation examples.

[0138] Figure 10 is the mass spectrum (LC-MS) of compound 1-82 prepared in synthesis example 5 of the compound preparation examples.

[0139] Figure 11 is the nuclear magnetic resonance (¹H NMR) spectrum of compound 1-82 prepared in synthesis example 5 of the compound preparation examples.

[0140] Figure 12 is the mass spectrum (LC-MS) of compounds 1-83 prepared in Synthesis Example 6 of the compound preparation examples.

[0141] Figure 13 is the nuclear magnetic resonance (¹H NMR) spectrum of compound 1-83 prepared in synthesis example 6 of the compound preparation examples.

[0142] Figure 14 is the mass spectrum (LC-MS) of compounds 1-84 prepared in Synthesis Example 7 of the compound preparation examples.

[0143] Figure 15 shows the nuclear magnetic resonance (¹H NMR) spectrum of compound 1-84 prepared in synthesis example 7 of the compound preparation examples.

[0144] Figure 16 is the mass spectrum (LC-MS) of compounds 1-89 prepared in Synthesis Example 8 of the compound preparation examples.

[0145] Figure 17 shows the nuclear magnetic resonance (¹H NMR) spectra of compounds 1-89 prepared in synthesis example 8 of the compound preparation examples.

[0146] Figure 18 is the mass spectrum (LC-MS) of compounds 1-90 prepared in Synthesis Example 8 in the compound preparation examples.

[0147] Figure 19 shows the nuclear magnetic resonance (¹H NMR) spectra of compounds 1-90 prepared in synthesis example 8 of the compound preparation examples. Detailed Implementation

[0148] Exemplary embodiments will now be described in detail, examples of which are illustrated in the accompanying drawings, wherein the same reference numerals always refer to the same elements. In this respect, these exemplary embodiments may take different forms and should not be construed as limited to the description set forth herein. Therefore, the exemplary embodiments are described below only by reference to the accompanying drawings to illustrate aspects. As used herein, the term “and / or” includes any and all combinations of one or more of the associated enumerated items. Expressions such as “at least one layer” modify the entire list of elements when preceding or following the list of elements, but do not modify individual elements of the list.

[0149] It will be further understood that the terms “comprising” or “including” as used in this specification indicate the presence of the stated features, regions, integrals, steps, operations, elements, and / or components, but do not preclude the presence or addition of one or more additional features, regions, integrals, steps, operations, elements, components, and / or sets thereof.

[0150] Unless otherwise defined, all terms used herein (including technical and scientific terms) have the same meaning as commonly understood by one of ordinary skill in the art to which this general application concept pertains. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having meanings consistent with their meanings in the relevant field and in the context of this disclosure, and will not be interpreted in an idealized or overly formal sense unless clearly defined herein.

[0151] The present application is further illustrated below with reference to specific embodiments. It should be understood that these embodiments are for illustrative purposes only and are not intended to limit the scope of protection of the present application. Furthermore, it should be understood that after reading the disclosure of the present application, those skilled in the art can make various alterations or modifications to the present application, and these equivalent forms also fall within the scope of protection defined by the present application.

[0152] In this application, unless otherwise specified, all parts and percentages are by weight, and the equipment and raw materials used are commercially available or commonly used in the art. Unless otherwise specified, the methods in the following embodiments are conventional methods in the art.

[0153] Unless otherwise specified, the experimental methods used in the following examples are conventional methods; the starting materials, reaction materials, reagents, and materials used in the following examples are all commercially available unless otherwise specified.

[0154] Compound preparation examples

[0155] LC-MS Brand: Waters, Model: SQ Detector 2

[0156] MRI brand: Bruker, model: AVANCE NEO 400

[0157] Those skilled in the art can synthesize the compounds of this application by referring to the following compounds and known synthetic methods.

[0158] Synthesis Example 1: Synthesis of Compound 1-1

[0159] (1) Synthesis of intermediate 1-1-1

[0160] Under a nitrogen atmosphere, 1-A (20.00 g, 40.99 mmol), 1-B (8.28 g, 40.99 mmol), potassium carbonate (11.31 g, 81.98 mmol), palladium acetate (0.18 g, 0.82 mmol), bis(2-diphenylphosphine) ether (0.88 g, 1.64 mmol), and 200 mL of 1,4-dioxane were added to a 500 mL four-necked reaction flask. The reaction mixture was heated to 110 °C and stirred. After reacting for 3 hours, the reaction mixture was cooled to 25 °C. 300 mL of dichloromethane and 100 mL of water were added to the reaction mixture, followed by extraction and separation. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (elution buffer volume ratio of dichloromethane:tetrahydrofuran = 10:1) to obtain intermediate 1-1-1 (12.90 g, yield 51.6%).

[0161] LC-MS (APCI): 611.25 [M+H] + .Calcd for:C 37 H 24 BrO2P.

[0162] (2) Synthesis of intermediate 1-1-2

[0163] Under a nitrogen atmosphere, intermediate 1-1-1 (10.00 g, 16.39 mmol), pinacol diborate (5.00 g, 19.67 mmol), potassium acetate (3.22 g, 32.78 mmol), 1,1'-bis(diphenylphosphine)ferrocene palladium dichloride (0.24 g, 0.33 mmol), and 1,4-dioxane (200 mL) were added to a 500 mL four-necked reaction flask. The reaction solution was heated to 100 °C. After 3 hours of reaction, the reaction solution was cooled to 25 °C. 200 mL of dichloromethane and 100 mL of water were added to the reaction solution, and the mixture was extracted and separated. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (eluent volume ratio of dichloromethane:tetrahydrofuran = 4:1) to obtain intermediate 1-1-2 (6.8 g, yield 63.0%).

[0164] LC-MS (APCI): 659.44 [M+H] + .Calcd for:C 43 H 36 BO4P.

[0165] (3) Synthesis of compound 1-1

[0166] Under a nitrogen atmosphere, intermediate 1-1-2 (6.50 g, 9.87 mmol), 1-C (3.30 g, 9.87 mmol), potassium carbonate (2.73 g, 19.74 mmol), tetraphenylphosphine palladium (0.23 g, 0.20 mmol), 50 mL tetrahydrofuran, and 15 mL water were added to a 250 mL four-necked reaction flask. The reaction mixture was heated to reflux and stirred for 4 hours, then cooled to 25 °C. 200 mL of dichloromethane and 100 mL of water were added to the reaction mixture, followed by extraction and separation. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (eluent volume ratio of dichloromethane:tetrahydrofuran = 2:1) to give a white compound 1-1 (5.60 g, yield 72.1%).

[0167] LC-MS (APCI): 787.46 [M+H] + .Calcd for:C 55 H 35 The corresponding mass spectrum for N2O2P is shown in Figure 2 of the instruction manual.

[0168] 1 H NMR(400MHz,Methylene Chloride-d2)δ8.54(dd,J=8.1,1.7Hz,1H),8.41(dt,J=6.2,1.4Hz,3H),8.33(dd,J=15.8,8.5Hz,2H),8. 20(d,J=8.5Hz,1H),8.14(dd,J=8.3,2.5Hz,2H),8.04(ddd,J=7.8,2.5,0.8Hz,1H),7.81(d,J=2.8Hz,2H), 7.74 (dd, J = 8.3, 6.9 Hz, 2H), 7.70–7.52 (m, 9H), 7.51–7.42 (m, 4H), 7.34 (dd, J = 8.3, 1.4 Hz, 2H), 7.27 (ddd, J = 8.4, 7.0, 1.6 Hz, 2H), 6.87 (ddd, J = 8.3, 7.0, 1.4 Hz, 2H), 6.56 (dd, J = 7.9, 1.6 Hz, 2H). See Appendix 3 in the specification for the corresponding NMR spectra.

[0169] Synthesis Example 2: Synthesis of Compounds 1-2

[0170] (1) Synthesis of intermediate 1-2-1

[0171] Under a nitrogen atmosphere, 1-D (22.20 g, 50 mmol), 1-B (10.10 g, 50 mmol), potassium carbonate (13.80 g, 100 mmol), palladium acetate (0.22 g, 1.00 mmol), bis(2-diphenylphosphine) ether (1.08 g, 2.00 mmol), and 250 mL of 1,4-dioxane were added to a 500 mL four-necked flask. The reaction mixture was heated to 110 °C and stirred. After reacting for 4 hours, the reaction mixture was cooled to 25 °C. 300 mL of dichloromethane and 100 mL of water were added to the reaction mixture, and the mixture was extracted and separated. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (eluent volume ratio of dichloromethane:tetrahydrofuran = 10:1) to give intermediate 1-2-1 (14.92 g, yield 52.7%).

[0172] LC-MS(APCI):567.28.Calcd for:C 37 H 24 ClO2P.

[0173] (2) Synthesis of intermediate 1-2-2

[0174] Under a nitrogen atmosphere, intermediate 1-2-1 (9.28 g, 16.39 mmol), pinacol diborate (5.00 g, 19.67 mmol), 2-dicyclohexylphosphine-2',4',6'-triisopropylbiphenyl (0.16 g, 0.33 mmol), palladium acetate (0.074 g, 0.33 mmol), and 200 mL of 1,4-dioxane were added to a 500 mL four-necked reaction flask. The reaction solution was heated to 100 °C. After 4 hours of reaction, the reaction solution was cooled to 25 °C. 300 mL of dichloromethane and 100 mL of water were added to the reaction solution, followed by extraction and separation. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (eluent volume ratio of dichloromethane:tetrahydrofuran = 6:1) to give intermediate 1-2-2 (6.61 g, yield 61.3%).

[0175] LC-MS (APCI): 659.51 [M+H] + .Calcd for:C 43 H 36 BO4P.

[0176] (3) Synthesis of compounds 1-2

[0177] Under a nitrogen atmosphere, intermediate 1-2-2 (6.00 g, 9.11 mmol), 1-C (3.04 g, 9.11 mmol), potassium carbonate (2.51 g, 18.22 mmol), tetraphenylphosphine palladium (0.23 g, 0.20 mmol), 50 mL tetrahydrofuran, and 15 mL water were added to a 250 mL four-necked reaction flask. The reaction solution was heated to reflux and stirred for 4 hours, then cooled to 25 °C. 300 mL dichloromethane and 100 mL water were added to the reaction solution, and the mixture was extracted and separated. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (eluent volume ratio of dichloromethane:tetrahydrofuran = 3:1) to give a white compound 1-2 (4.91 g, yield 68.5%).

[0178] LC-MS (APCI): 787.46 [M+H] + .Calcd for:C 55 H 35 The corresponding mass spectrum for N2O2P is shown in Figure 4 of the instruction manual.

[0179] 1 H NMR(400MHz,Methylene Chloride-d2)δ8.48(dd,J=8.0,1.6Hz,1H),8.46–8.40(m,2H),8.40–8.30(m,3H),8.21(d ,J=8.5Hz,1H),8.12(d,J=8.4Hz,1H),8.01(dd,J=8.0,0.6Hz,1H),7.89(dt,J=7.6,0.9Hz 7.83 (s, 2H), 7.75–7.66 (m, 2H), 7.65–7.58 (m, 1H), 7.51–7.20 (m, 17H), 6.91 (ddd, J = 8.3, 7.1, 1.3 Hz, 1H), 6.81–6.71 (m, 1H), 6.60 (dd, J = 7.9, 1.6 Hz, 1H). The corresponding NMR spectra are shown in Figure 5 of the specification.

[0180] Synthesis Example 3: Synthesis of Compounds 1-3

[0181] (1) Synthesis of intermediate 1-3-1

[0182] Under a nitrogen atmosphere, 1-E (22.20 g, 50 mmol), 1-B (10.10 g, 50 mmol), potassium carbonate (13.80 g, 100 mmol), palladium acetate (0.22 g, 1.00 mmol), bis(2-diphenylphosphine) ether (1.08 g, 2.00 mmol), and 250 mL of 1,4-dioxane were added to a 500 mL four-necked flask. The reaction mixture was heated to 110 °C and stirred. After reacting for 3 hours, the reaction mixture was cooled to 25 °C. 300 mL of dichloromethane and 100 mL of water were added to the reaction mixture, and the mixture was extracted and separated. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (eluent volume ratio of dichloromethane:tetrahydrofuran = 10:1) to give intermediate 1-3-1 (16.50 g, yield 58.3%).

[0183] LC-MS (APCI): 67.39 [M+H] + .Calcd for:C 37 H 24 ClO2P.

[0184] (2) Synthesis of intermediate 1-3-2

[0185] Under a nitrogen atmosphere, intermediate 1-3-1 (9.28 g, 16.39 mmol), pinacol diborate (5.00 g, 19.67 mmol), potassium acetate (3.22 g, 32.78 mmol), 2-dicyclohexylphosphine-2',4',6'-triisopropylbiphenyl (0.16 g, 0.33 mmol), palladium acetate (0.074 g, 0.33 mmol), and 1,4-dioxane (200 mL) were added to a 500 mL four-necked reaction flask. The reaction solution was heated to 100 °C. After 4 hours of reaction, the reaction solution was cooled to 25 °C. 300 mL of dichloromethane and 100 mL of water were added to the reaction solution, followed by extraction and separation. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (eluent volume ratio of dichloromethane:tetrahydrofuran = 5:1) to obtain intermediate 1-3-2 (6.17 g, yield 57.2%).

[0186] LC-MS (APCI): 659.48 [M+H] + .Calcd for:C 43 H 36 BO4P.

[0187] (3) Synthesis of compounds 1-3

[0188] Under a nitrogen atmosphere, intermediate 1-3-2 (6.00 g, 9.11 mmol), 1-C (3.04 g, 9.11 mmol), potassium carbonate (2.51 g, 18.22 mmol), tetraphenylphosphine palladium (0.23 g, 0.20 mmol), 50 mL tetrahydrofuran, and 15 mL water were added to a 250 mL four-necked reaction flask. The reaction solution was heated to reflux and stirred for 4 hours. The reaction solution was then cooled to 25 °C to precipitate a solid. 250 mL of dichloromethane and 100 mL of water were added to the reaction solution, and the mixture was extracted and separated. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (eluent volume ratio of dichloromethane:tetrahydrofuran = 3:1) to give a white compound 1-3 (5.12 g, yield 71.4%).

[0189] LC-MS (APCI): 787.43 [M+H] + .Calcd for:C 55 H 35 The corresponding mass spectrum for N2O2P is shown in Figure 6 of the instruction manual.

[0190] 1 ¹H NMR (400MHz, Methylene Chloride-d²) δ 8.53 (dd, J = 8.6, 2.2Hz, 1H), 8.40–8.29 (m, 3H), 8.14 (dd, J = 8.4, 2.1Hz, 2H), 8.01–7.92 (m, 2H), 7.80–7.72 (m, 2H), 7.71–7.18 (m, 2³H), 6.85 (ddd, J = 7.8, 6.4, 2.0Hz, 1H), 6.48–6.42 (m, 1H). The corresponding NMR spectra are shown in Figure 7 of the specification.

[0191] Synthesis Example 4: Synthesis of Compounds 1-7

[0192] (1) Synthesis of intermediate 1-7-1

[0193] Under a nitrogen atmosphere, 1-F (30.00 g, 61.48 mmol), 1-B (12.42 g, 61.48 mmol), potassium carbonate (16.92 g, 122.42 mmol), palladium acetate (0.27 g, 1.20 mmol), bis(2-diphenylphosphine) ether (0.65 g, 1.20 mmol), and 300 mL of 1,4-dioxane were added to a 500 mL four-necked reaction flask. The reaction mixture was heated to 110 °C and stirred. After reacting for 2 hours, the reaction mixture was cooled to 25 °C. 300 mL of dichloromethane and 100 mL of water were added to the reaction mixture, followed by extraction and separation. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (elution buffer volume ratio of dichloromethane:tetrahydrofuran = 10:1) to obtain intermediate 1-7-1 (20.03 g, yield 53.4%).

[0194] LC-MS (APCI): 611.25 [M+H] + .Calcd for:C 25 H 14 Br2O.

[0195] (2) Synthesis of intermediate 1-7-2

[0196] Under a nitrogen atmosphere, intermediate 1-7-1 (20 g, 32.78 mmol), pinacol diborate (10.00 g, 39.34 mmol), potassium acetate (6.44 g, 65.56 mmol), 1,1'-bis(diphenylphosphine)ferrocene palladium dichloride (0.48 g, 0.66 mmol), and 1,4-dioxane (300 mL) were added to a 500 mL four-necked reaction flask. The reaction solution was heated to 100 °C. After 4 hours of reaction, the reaction solution was cooled to 25 °C. 300 mL of dichloromethane and 100 mL of water were added to the reaction solution, and the mixture was extracted and separated. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (eluent volume ratio of dichloromethane:tetrahydrofuran = 5:1) to obtain intermediate 1-7-2 (18.07 g, yield 83.7%).

[0197] LC-MS (APCI): 659.44 [M+H] + .Calcd for:C 43 H 36 BO4P.

[0198] (3) Synthesis of compounds 1-7

[0199] Under a nitrogen atmosphere, intermediate 1-7-2 (10.00 g, 15.19 mmol), 1-C (5.34 g, 15.93 mmol), potassium carbonate (3.14 g, 22.75 mmol), dichlorobis(triphenylphosphine)palladium (0.21 g, 0.30 mmol), 200 mL tetrahydrofuran, and 50 mL water were added to a 500 mL four-necked reaction flask. The reaction solution was heated to 80 °C and stirred for 2 hours, then cooled to 25 °C. 300 mL of dichloromethane and 100 mL of water were added to the reaction solution, followed by extraction and separation. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (eluent volume ratio of dichloromethane:tetrahydrofuran = 3:1) to give a white compound 1-7 (8.04 g, yield 67.2%).

[0200] LC-MS (APCI): 787.43 [M+H] + .Calcd for:C 55 H 35 The corresponding mass spectrum for N2O2P is shown in Figure 8 of the instruction manual.

[0201] 1 ¹H NMR (400MHz, Methylene Chloride-d²) δ 8.54 (dd, J = 8.6, 2.2Hz, 1H), 8.39–8.31 (m, 3H), 8.16 (dd, J = 8.5, 1.8Hz, 2H), 7.84 (dt, J = 7.7, 1.0Hz, 2H), 7.77 (q, J = 8.7Hz, 2H), 7.71–7.64 (m, 3H), 7.62–7.56 (m, 2H), 7.54–7.47 (m, 3H), 7.47–7.34 (m, 11H), 7.32–7.23 (m, 5H), 6.66 (dd, J = 12.3, 1.9Hz, 1H). The corresponding NMR spectra are shown in Figure 9 of the specification.

[0202] Synthesis Example 5: Synthesis of Compounds 1-82

[0203] (1) Synthesis of intermediate 1-82-1

[0204] The synthesis of intermediate 1-82-1 is the same as that of intermediate 1-3-1, except that 1-G is used instead of 1-E.

[0205] LC-MS (APCI): 567.42 [M+H] + .Calcd for:C 37 H 24 ClO2P.

[0206] (2) Synthesis of intermediate 1-82-2

[0207] The synthesis of intermediate 1-82-2 is the same as that of intermediate 1-3-2, except that intermediate 1-82-1 is used instead of intermediate 1-3-1.

[0208] LC-MS (APCI): 659.48 [M+H] + .Calcd for:C 43 H 36 BO4P.

[0209] (3) Synthesis of compounds 1-82

[0210] The synthesis of compounds 1-82 is the same as that of compounds 1-3, except that intermediate 1-3-2 is replaced by intermediate 1-82-2.

[0211] LC-MS (APCI): 787.46 [M+H] + .Calcd for:C 55 H 35 The mass spectrum corresponding to N2O2P is shown in Figure 10 of the instruction manual.

[0212] 1 ¹H NMR (400MHz, Methylene Chloride-d²) δ 8.42 (dd, J = 8.3, 3.6Hz, 2H), 8.28 (dd, J = 7.4, 2.2Hz, 2H), 8.19 (d, J = 8.4Hz, 1H), 7.96 (s, 2H), 7.82 (d, J = 8.2Hz, 1H), 7.65 (d, J = 7.5Hz, 1H), 7.51–7.23 (m, 20H), 7.13 (d, J = 4.2Hz, 2H), 6.98 (dq, J = 8.3, 4.1Hz, 1H), 6.93–6.85 (m, 1H), 6.70 (dd, J = 12.4, 1.9Hz, 1H), 6.65–6.60 (m, 1H). The corresponding NMR spectra are shown in Figure 11 of the specification.

[0213] Synthesis Example 6: Synthesis of Compounds 1-83

[0214] (1) Synthesis of intermediate 1-83-1

[0215] The synthesis of intermediate 1-83-1 is the same as that of intermediate 1-3-1, except that 1-E is replaced by 1-H.

[0216] LC-MS (APCI): 567.35 [M+H] + .Calcd for:C 37 H 24 ClO2P.

[0217] (2) Synthesis of intermediate 1-83-2

[0218] The synthesis of intermediate 1-83-2 is the same as that of intermediate 1-3-2, except that intermediate 1-83-1 is used instead of intermediate 1-3-1.

[0219] LC-MS (APCI): 659.48 [M+H] + .Calcd for:C 43 H 36 BO4P.

[0220] (3) Synthesis of compounds 1-83

[0221] The synthesis of compound 1-83 is the same as that of compound 1-3, except that intermediate 1-3-2 is replaced by intermediate 1-83-2.

[0222] LC-MS (APCI): 787.46 [M+H] + .Calcd for:C 55 H 35 For the mass spectrum of O2N2P, please refer to Figure 12 in the instruction manual.

[0223] 1 H NMR (400MHz, Methylene) Chloride-d2)δ 8.87(d,J=1.6Hz,1H), 8.52(dd,J=7.3,1.7Hz,2H), 8.39(dd,J=12.2,8.4Hz,2H), 8.32–8.20(m,3H), 7.98(d,J=7.6Hz,1H), 7.87(s,2H), 7.61(t,J=7.6Hz,2H), 7.54–7.21(m,18H), 7.17(d,J=7.6Hz,1H), 6.87(td,J=7.4,6.9,1.5Hz,1H), 6.67(dd,J=12.3,1.9Hz,1H), 6.54(dd,J=7.9,1.5Hz,1H). The corresponding NMR spectra are shown in Figure 13 of the specification.

[0224] Synthesis Example 7: Synthesis of Compounds 1-84

[0225] (1) Synthesis of intermediate 1-84-1

[0226] The synthesis of intermediate 1-84-1 is the same as that of intermediate 1-3-1, except that 1-E is replaced by 1-I.

[0227] LC-MS (APCI): 567.39 [M+H] + .Calcd for:C 37 H 24 ClO2P.

[0228] (2) Synthesis of intermediate 1-84-2

[0229] The synthesis of intermediate 1-84-2 is the same as that of intermediate 1-3-2, except that intermediate 1-3-1 is replaced by intermediate 1-84-1.

[0230] LC-MS (APCI): 659.48 [M+H] + .Calcd for:C 43 H 36 BO4P.

[0231] (3) Synthesis of compounds 1-84

[0232] The synthesis of compound 1-84 is based on the same method as that of compound 1-3, except that intermediate 1-3-2 is replaced by intermediate 1-84-2.

[0233] LC-MS (APCI): 787.39 [M+H] + .Calcd for:C 55 H 35 For the mass spectrum of O2N2P, please refer to Figure 14 in the instruction manual.

[0234] 1H NMR(400MHz,Methylene Chloride-d2)δ8.55(dd,J=8.2,1.6Hz,1H),8.42–8.25(m,5H),8.17(d,J=8.4Hz,1H),8.09(t,J=7.7 Hz,2H),7.94(d,J=7.6Hz,1H),7.78(d,J=1.7Hz,2H),7.66–7.55(m,7H),7.54–7.44(m,4H),7.38(dt The corresponding NMR spectra are shown in Figure 15 of the specification. (d, J = 10.6, 7.5, 2.8 Hz, 4H), 7.33–7.24 (m, 3H), 7.20 (d, J = 7.5 Hz, 1H), 7.02 (ddd, J = 11.0, 8.0, 1.5 Hz, 1H), 6.89–6.82 (m, 1H), 6.62 (dd, J = 8.0, 3.4 Hz, 1H), 6.56 (dd, J = 7.9, 1.5 Hz, 1H).

[0235] Synthesis Example 8: Synthesis of Compounds 1-89

[0236] (1) Synthesis of intermediate 1-89-1

[0237] The synthesis of intermediate 1-89-1 is the same as that of intermediate 1-3-1, except that 1-E is replaced by 1-J.

[0238] LC-MS (APCI): 567.39 [M+H] + .Calcd for:C 37 H 24 ClO2P.

[0239] (2) Synthesis of intermediate 1-89-2

[0240] The synthesis of intermediate 1-89-2 is the same as that of intermediate 1-3-2, except that intermediate 1-3-1 is replaced by intermediate 1-89-1.

[0241] LC-MS (APCI): 659.51 [M+H] + .Calcd for:C 43 H 36 BO4P.

[0242] (3) Synthesis of compounds 1-89

[0243] The synthesis of compounds 1-89 is based on the same method as that of compounds 1-3, except that intermediate 1-3-2 is replaced by intermediate 1-89-2.

[0244] LC-MS (APCI): 787.93 [M+H] + .Calcd for:C 55 H 35 The corresponding mass spectrum for N2O2P is shown in Figure 16 of the instruction manual.

[0245] 1 H NMR(400MHz,Methylene Chloride-d2)δ8.44(dd,J=21.9,8.3Hz,2H),8.32–8.14(m,3H),8.05(d,J=8.2Hz,1H),7. 95(s,2H),7.68(dd,J=12.7,7.2Hz,5H),7.62–7.37(m,12H),7.33–7.23(m,3H),7.21–7.1 2(m, 2H), 7.07(ddd, J = 11.0, 7.9, 1.6Hz, 1H), 7.00(td, J = 7.2, 6.5, 1.9Hz, 1H), 6.88(dq, J = 8.3, 4.5Hz, 1H), 6.70(dd, J = 8.0, 3.4Hz, 1H), 6.60(d, J = 7.8Hz, 1H). The corresponding NMR spectra are shown in Figure 17 of the specification.

[0246] Synthesis Example 9: Synthesis of Compounds 1-90

[0247] (1) Synthesis of intermediate 1-90-1

[0248] Under nitrogen protection, 1-L (29.18 g, 109 mmol) was placed in a 1000 mL four-necked reaction flask, followed by the addition of 150 mL of tetrahydrofuran. The mixture was purged with nitrogen three times, and the temperature was lowered to -78 °C with liquid nitrogen. 41.80 mL of n-butyllithium was then slowly added dropwise, maintaining the temperature at -78 °C throughout this process. 1-K (25.00 g, 91 mmol) was added to 850 mL of tetrahydrofuran solution and then slowly added dropwise to the reaction flask over 1 hour, maintaining the temperature at -78 °C throughout this process. After the addition was complete, the temperature was naturally raised to 25 °C, and the reaction was completed after 2 hours. 500 mL of water was added, and the mixture was extracted and separated. The organic phase was dried over anhydrous sodium sulfate, and the organic phase was concentrated to obtain the crude product. The crude product was purified by column chromatography (eluent volume ratio of n-hexane:dichloromethane = 5:1) to obtain intermediate 1-90-1 (28.50 g, yield 67.6%).

[0249] LC-MS (APCI): 447.23 [M+H] +.Calcd for:C 25 H 16 O2ClBr.

[0250] (2) Synthesis of intermediate 1-90-2

[0251] Under nitrogen protection, intermediate 1-90-1 (28.50 g, 61 mmol) was placed in a 250 mL four-necked reaction flask, 150 mL of acetic acid was added, followed by 7.5 mL of concentrated sulfuric acid. The mixture was purged with nitrogen three times and heated to 100 °C. After 2 hours, the reaction was complete, and a solid precipitated. The reaction solution was cooled to 25 °C, filtered, washed with 100 mL of ethanol, and dried to obtain intermediate 1-90-2 (19.90 g, yield 72.7%).

[0252] LC-MS (APCI): 445.23 [M+H] + .Calcd for:C 25 H 14 OClBr.

[0253] (3) Synthesis of intermediate 1-90-3

[0254] The synthesis of intermediate 1-90-3 is the same as that of intermediate 1-3-1, except that 1-E is replaced by intermediate 1-90-2.

[0255] LC-MS (APCI): 567.39 [M+H] + .Calcd for:C 37 H 24 O2ClP.

[0256] (4) Synthesis of intermediate 1-90-4

[0257] The synthesis of intermediate 1-90-4 is the same as that of intermediate 1-3-2, except that intermediate 1-90-3 is used instead of intermediate 1-3-1.

[0258] LC-MS (APCI): 659.48 [M+H] + .Calcd for:C 43 H 36 O4BP.

[0259] (5) Synthesis of compounds 1-90

[0260] The synthesis of compounds 1-90 is based on the same method as that of compounds 1-3, except that intermediate 1-3-2 is replaced by intermediate 1-90-4.

[0261] LC-MS (APCI): 787.43 [M+H] + .Calcd for:C 55 H 35 For the mass spectrum of O2N2P, please refer to Figure 18 in the instruction manual.

[0262] 1 H NMR(400MHz,Methylene Chloride-d2)δ9.03(d,J=1.6Hz,1H),8.65–8.50(m,2H),8.42(t,J=8.3Hz,2H),8.34–8.23(m,3 H),8.12(d,J=7.6Hz,1H),7.89(s,2H),7.74–7.64(m,6H),7.62–7.49(m,9H),7.43(d,J=7.9Hz,1 7.34 (td, J = 7.5, 1.1 Hz, 1H), 7.31–7.24 (m, 3H), 7.08 (ddd, J = 11.0, 8.0, 1.6 Hz, 1H), 6.89 (ddd, J = 8.2, 5.0, 3.4 Hz, 1H), 6.66 (dd, J = 8.0, 3.4 Hz, 1H), 6.57 (d, J = 7.9 Hz, 1H). The corresponding NMR spectra are shown in Figure 19 of the specification.

[0263] The following application examples further illustrate the use of the spirofluorene xanthracene compounds described in this application in the preparation of organic electroluminescent devices.

[0264] Application Example 1

[0265] This embodiment provides an organic electroluminescent element, as shown in FIG1, comprising a first electrode layer 1, a hole injection layer 2, a hole transport layer 3, a second hole transport layer 4, a light-emitting layer 5, a hole blocking layer 6, an electron transport layer 7, an N-type charge generation layer 8, a P-type charge generation layer 9, a hole transport layer 10, a second hole transport layer 11, a light-emitting layer 12, a hole blocking layer 13, an electron transport layer 14, an electron injection layer 15, and a second electrode layer 16, wherein 100 is a first light-emitting unit and 200 is a second light-emitting unit.

[0266] The specific device structure is as follows:

[0267] ITO / HT:PD(3%)(10nm) / HT / (60nm) / EB(5nm) / BH:BD(3%)(20nm) / HB(5nm) / ET-L iq(50%)(10nm) / REF-1:Yb(1%)(10nm) / HT:PD(10%)(10nm) / HT(60nm) / EB(5nm) /

[0268] BH:BD(3%)(20nm) / HB(5nm) / ET-LiQ(50%)(20nm) / Yb(1.5nm) / Mg:Ag 1:9(100nm).

[0269] Device fabrication process:

[0270] The bottom-emitting glass substrate 1 used in this embodiment was purchased from Guangdong Xinli Display Technology Co., Ltd., and ITO was used as the anode 2. First, the bottom-emitting glass substrate was cleaned sequentially with ITO cleaning agent, deionized water, and isopropanol. Then, the bottom-emitting glass substrate was baked at 180 degrees Celsius for 30 minutes to dry it.

[0271] Then, the bottom-emitting glass substrate is placed in the evaporation chamber, under a vacuum of approximately 10... -8 Under the condition of T, organic layers were sequentially deposited on the ITO anode by thermal vacuum evaporation at a rate of 0.2-2 Å / s. PD (3%) was doped into HT to form a 10 nm thick layer as a hole injection layer. HT was formed to a thickness of 60 nm as a hole transport layer, and a 5 nm thick EB material was deposited on it as a second hole transport layer. Then, 3% BD was doped onto BH to form a 20 nm thick blue emitting layer, and a 5 nm thick HB was deposited on it as a hole blocking material. ET was doped with 50% LiQ to form a 10 nm thick electron transport layer. REF-1 was doped with 1% Yb to form a 10 nm thick N-type charge generation layer. Finally, 10% PD was doped into HT to form a 10 nm thick P-type charge generation layer. The device is constructed using a layered process. Compound HT is deposited as a 60 nm thick hole transport layer. A 5 nm thick EB material is then deposited on top as a second hole transport layer. Subsequently, 3% BD is doped onto BH to form a 20 nm thick blue emitting layer. A 5 nm thick HB material is then deposited on the blue emitting layer as a hole blocking material. ET, doped with 50% LiQ, is formed as a 20 nm thick electron transport layer. Yb is formed as a 1.5 nm thick electron injection layer. Mg:Ag (1:9) is formed as a 100 nm thick cathode. In this embodiment, different materials are used to deposit the same layers in a specific volume ratio, for example, 50% LiQ is a volume ratio of 50% ET and 50% LiQ. The materials used in this application are purified by sublimation, with an HPLC purity of 99.9%.

[0272] Finally, the device was transferred back to the glove box and sealed with a glass cover and desiccant to complete the device, which is referred to as Device Comparison Example 1.

[0273] The specific structures of the compounds involved are as follows:

[0274] Device Comparison Example 2

[0275] An N-type charge generation layer was prepared by replacing compound REF-1 with compound REF-2, and device 2 was fabricated using the same method as device comparative example 1, and is referred to as comparative example 2.

[0276] Device Comparison Example 3

[0277] An N-type charge generation layer was prepared by replacing compound REF-1 with compound REF-3, and device 3 was fabricated using the same method as device Comparative Example 1, and is referred to as Comparative Example 3.

[0278] Device Comparison Example 4

[0279] An N-type charge generation layer was prepared by replacing compound REF-1 with compound REF-4, and device 4 was fabricated using the same method as device comparative example 1, and is referred to as comparative example 4.

[0280] Device Comparison Example 5

[0281] An N-type charge generation layer was prepared by replacing compound REF-1 with compound REF-5, and device 5 was fabricated using the same method as device comparative example 1. This device is referred to as comparative example 5.

[0282] Device Comparison Example 6

[0283] An N-type charge generation layer was prepared by replacing compound REF-1 with compound REF-6, and device 6 was fabricated using the same method as Comparative Example 1. This device is designated as Comparative Example 6.

[0284] Device Comparison Example 7

[0285] An N-type charge generation layer was prepared by replacing compound REF-1 with compound REF-7, and device 7 was fabricated using the same method as in Comparative Example 1. This device is designated as Comparative Example 7.

[0286] Device Comparison Example 8

[0287] An N-type charge generation layer was prepared by replacing compound REF-1 with compound REF-8, and device 8 was fabricated using the same method as Comparative Example 1. This device is referred to as Comparative Example 8.

[0288] Device Example 1

[0289] An N-type charge generation layer was prepared by replacing compound REF-1 with compound 1-1 synthesized in this application, and device 9 was fabricated using the same method as in Device Comparative Example 1. This is referred to as Example 1.

[0290] Device Example 2

[0291] The N-type charge generation layer was prepared by replacing compound REF-1 with compound 1-2 synthesized in this application, and device 10 was fabricated using the same method as in device comparative example 1. This is referred to as Example 2.

[0292] Device Example 3

[0293] The N-type charge generation layer was prepared by replacing compound REF-1 with compounds 1-3 synthesized in this application, and device 11 was fabricated using the same method as in Device Comparative Example 1. This is referred to as Example 3.

[0294] Device Example 4

[0295] The N-type charge generation layer was prepared by replacing compound REF-1 with compounds 1-7 synthesized in this application, and device 12 was fabricated using the same method as in Device Comparative Example 1. This is referred to as Example 4.

[0296] Device Example 5

[0297] The N-type charge generation layer was prepared by replacing compound REF-1 with compound 1-82 synthesized in this application, and device 13 was fabricated using the same method as in device comparative example 1. This is referred to as Example 5.

[0298] Device Example 6

[0299] The N-type charge generation layer was prepared by replacing compound REF-1 with compound 1-83 synthesized in this application, and device 14 was fabricated using the same method as in device comparative example 1, which is referred to as Example 6.

[0300] Device Example 7

[0301] The N-type charge generation layer was prepared by replacing compound REF-1 with compound 1-84 synthesized in this application, and device 15 was fabricated using the same method as in device comparative example 1, which is referred to as Example 7.

[0302] Device Example 8

[0303] The N-type charge generation layer was prepared by replacing compound REF-1 with compound 1-89 synthesized in this application, and device 16 was fabricated using the same method as in Device Comparative Example 1, which is referred to as Example 8.

[0304] Device Example 9

[0305] The N-type charge generation layer was prepared by replacing compound REF-1 with compound 1-90 synthesized in this application, and device 17 was fabricated using the same method as in device comparative example 1, which is referred to as Example 9.

[0306] Test Results

[0307] Lifetime testing method: Apply voltage to the obtained device to achieve a current density of 30 mA / cm². 2 The time it takes for the brightness to become 95% of the initial brightness is measured (LT95 (unit: hours)).

[0308] Drive voltage and efficiency at a current density of 15 mA / cm² 2 Next test.

[0309] The test results are shown in Table 1.

[0310] Table 1

[0311] As can be seen from Table 1, the compounds of this application, when used as stacked devices prepared by N-CGL, have lower voltage and longer lifespan. Therefore, the compounds of this application are suitable for preparing high-performance organic electroluminescent elements.

[0312] Those skilled in the art will readily understand that the above description is merely a preferred embodiment of this application and is not intended to limit this application. Any modifications, equivalent substitutions, and improvements made within the spirit and principles of this application should be included within the protection scope of this application.

Claims

1. A spiro fluorene xanthene compound, having a structure as shown in the following formula 1: wherein, In the compounds of the structure of Formula 1, Ar 1 , Ar 2 is hydrogen and the other is a group of the structure of Formula 2: In the groups of the structure of Formula 2, R 1 , R 2 each independently is selected from substituted or unsubstituted C1-C 10 alkyl, substituted or unsubstituted C6-C 60 aryl; L 1 Selected from linker, substituted or unsubstituted C6-C 60 Alpha-aryl; In the compounds of structure 1, Ar 3 , Ar 4 is hydrogen and the other is a group of the following structure 3: In the groups of the structure of Formula 3, R 3 selected from hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C1-C 10 alkyl, substituted or unsubstituted C6-C 60 aryl, substituted or unsubstituted C2-C 60 heteroaryl; n is an integer from 0 to 7; when n is 2 or more, the plurality of R 3 each other or different from each other; Indicates a connection key; The substituents in the "substituted or unsubstituted" group are each independently selected from deuterium, halogen, cyano, C1-C. 10 Alkyl, C1-C 10 alkoxy groups, C3-C 10 cycloalkyl, C3-C 10 Cycloalkoxy, C6-C 60 aryl, C6-C 60 aryloxy groups, C2-C 60 One or a combination of heteroaryl groups; The heteroatom in the heteroaryl group is selected from one or more of N, O, S, Si, P, and B; The above compounds may or may not contain at least one substituent selected from deuterium, fluorine, or cyano.

2. The spirofuroxan xanthene compound according to claim 1, wherein, the group of the structure of Formula 2 is selected from the following structures: wherein R 1 , R 2 are each independently selected from substituted or unsubstituted methyl, substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, preferably from wherein L 1 is as defined above; Indicates a connection key; The definition of substituents in "substituted or unsubstituted" is the same as above; The above groups are either unsubstituted or substituted by one or more substituents selected from deuterium, fluorine, and cyano.

3. The spirofuroxan xanthene compound according to claim 1, wherein, The structure of the spirofused fluorene oxepin compound is shown in the following Formula 4, Formula 5, Formula 6, or Formula 7: wherein Ar 3 , Ar 4 is a group of the following formula 3: L 1 、R 3 、n are as defined above; Indicates a connection key; The above compounds may or may not contain at least one substituent selected from deuterium, fluorine, or cyano.

4. The spirofuroxan xanthene compound according to any one of claims 1 to 3, wherein, the group of the structure of Formula 3 is selected from the following structures: R 3 is hydrogen, deuterium, substituted or unsubstituted phenyl, substituted or unsubstituted pyridyl, and n is as defined above; The group of the structure of formula 3 is preferably selected from the following structures: R 3 R is as defined above; and R is as defined above; and wherein, Indicates a connection key; The definition of substituents in "substituted or unsubstituted" is the same as above; The above groups are either unsubstituted or substituted by one or more substituents selected from deuterium, fluorine, and cyano.

5. The spirofuroxan xanthene compound according to any one of claims 1 to 3, wherein, The structure of the spiro fluorene xanthene compound is as shown in the following formula 4-1, formula 4-2, formula 5-1, formula 5-2, formula 6-1, formula 6-2, formula 7-1, or formula 7-2: wherein L 1 , R 3 are as defined above; The above compounds may or may not contain at least one substituent selected from deuterium, fluorine, or cyano.

6. The spirofuroxan xanthene compound according to any one of claims 1 to 5, wherein, The spirofused oxepine compound structure is selected from the group consisting of: wherein Indicates a replacement position; two of the above mentioned spiro fluorene xanthene groups one is directly attached to the L 1 directly attached to the other phenanthrolinyl group; The above groups are either unsubstituted or substituted by one or more substituents selected from deuterium, fluorine, and cyano.

7. The spirofuroxan xanthene compound according to any one of claims 1 to 5, wherein, The structure of the spirofuranoxanthene compound is as shown below: Preferably as shown below wherein L 1 , R 3 are as defined above; The above compounds may or may not contain at least one substituent selected from deuterium, fluorine, or cyano.

8. The spirofuroxan xanthene compound according to any one of claims 1 to 7, wherein, said L 1 is selected from a bond, substituted or unsubstituted phenylene, substituted or unsubstituted naphthylene, the substituents in "substituted or unsubstituted" being as defined above; the aforementioned groups being unsubstituted or substituted by one or more substituents selected from deuterium, fluoro, cyano.

9. The spirofuroxan xanthene compound of claim 1, wherein, The spirofused fluorene oxepin compound is selected from the group consisting of the structures shown below:

10. A material for an organic element comprising the spirofluorenexanthracene compound as described in any one of claims 1-9; preferably, the material is an electron transport layer material, a hole blocking layer material, an electron injection layer material, or a charge generation layer material.

11. An organic electroluminescent element comprising the spirofluorenexanthracene compound according to any one of claims 1-9 or the organic element material according to claim 10; Preferably, the organic electroluminescent element includes a cathode, an anode, and an organic functional layer located between the anode and the cathode, wherein at least one of the organic functional layers contains a spirofluorenexanthracene compound as described in any one of claims 1-9 or a material for organic elements as described in claim 10; More preferably, the organic layer comprises at least two light-emitting units, and a charge-generating layer is provided between the light-emitting units. The charge-generating layer comprises an N-type charge-generating layer and a P-type charge-generating layer, and the N-type charge-generating layer comprises a spirofluorenexanthracene compound with the general structure shown in Formula 1 of claim 1.

12. A display or lighting device comprising a spirofluorenexanthracene compound as described in any one of claims 1-9, an organic element material as described in claim 10, or an organic electroluminescent element as described in any one of claims 11.